Interleukins in glioblastoma pathophysiology: implications for therapy.
about
TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastomaMERTK Inhibition Induces Polyploidy and Promotes Cell Death and Cellular Senescence in Glioblastoma MultiformeCaspase-8 contributes to angiogenesis and chemotherapy resistance in glioblastoma.Hypoxia suppresses cylindromatosis (CYLD) expression to promote inflammation in glioblastoma: possible link to acquired resistance to anti-VEGF therapy.Mechanisms and applications of interleukins in cancer immunotherapy.The prognostic role of preoperative serum albumin levels in glioblastoma patients.Silencing of the tumor suppressor gene WNK2 is associated with upregulation of MMP2 and JNK in gliomas.Engraftment of Human Glioblastoma Cells in Immunocompetent Rats through Acquired Immunosuppression.Oncogenic Ras modulates p38 MAPK-mediated inflammatory cytokine production in glioblastoma cells.Examination of Epigenetic and other Molecular Factors Associated with mda-9/Syntenin Dysregulation in Cancer Through Integrated Analyses of Public Genomic DatasetsUsing the molecular classification of glioblastoma to inform personalized treatment.Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas.The Dynamics of Interactions Among Immune and Glioblastoma Cells.The potential roles of dopamine in malignant glioma.Topological robustness analysis of protein interaction networks reveals key targets for overcoming chemotherapy resistance in glioma.Regulation of IL-8 gene expression in gliomas by microRNA miR-93.The Transcription Factor ZNF395 Is Required for the Maximal Hypoxic Induction of Proinflammatory Cytokines in U87-MG Cells.Biological Response Modifier in Cancer Immunotherapy.Astrocytic growth through the autocrine/paracrine production of IL-1β in the early infectious phase of fowl glioma-inducing virus.Interleukin-33 in human gliomas: Expression and prognostic significance.Integrative Analysis of mRNA, microRNA, and Protein Correlates of Relative Cerebral Blood Volume Values in GBM Reveals the Role for Modulators of Angiogenesis and Tumor Proliferation.Effect of 10 different polymorphisms on preoperative volumetric characteristics of glioblastoma multiforme.Nitroproteins in Human Astrocytomas Discovered by Gel Electrophoresis and Tandem Mass Spectrometry.CD133 Regulates IL-1β Signaling and Neutrophil Recruitment in Glioblastoma.Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O6-methylguanine-DNA methyltransferase.Preoperative inflammation markers and IDH mutation status predict glioblastoma patient survival.TLR4 interaction with LPS in glioma CD133+ cancer stem cells induces cell proliferation, resistance to chemotherapy and evasion from cytotoxic T lymphocyte-induced cytolysis.Prognostic role of neutrophil lymphocyte ratio in patients with glioma.Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen.Solasonine inhibits glioma growth through anti-inflammatory pathways.Loss of C/EBPδ enhances IR-induced cell death by promoting oxidative stress and mitochondrial dysfunction.MicroRNA-378 enhances inhibitory effect of curcumin on glioblastoma.P2Y14 receptor activation decreases interleukin-6 production and glioma GL261 cell proliferation in microglial transwell cultures.Pediatric glioblastoma cells inhibit neurogenesis and promote astrogenesis, phenotypic transformation and migration of human neural progenitor cells within cocultures.Inhibition of p38 MAPK activity leads to cell type-specific effects on the molecular circadian clock and time-dependent reduction of glioma cell invasiveness.Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma.Anti-inflammatory Effects of Atorvastatin by Suppressing TRAF3IP2 and IL-17RA in Human Glioblastoma Spheroids Cultured in a Three-dimensional Model: Possible Relevance to Glioblastoma Treatment.The p38-MK2-HuR pathway potentiates EGFRvIII-IL-1β-driven IL-6 secretion in glioblastoma cells.Cysteinyl Leukotriene Receptor Antagonists Inhibit Migration, Invasion, and Expression of MMP-2/9 in Human Glioblastoma.RUNX1 Regulates Migration, Invasion, and Angiogenesis via p38 MAPK Pathway in Human Glioblastoma.
P2860
Q28390726-93CF23D2-D8EE-4B68-98E1-D07A5AD31C2FQ28552962-1F4836BD-7EAB-4F8E-98F3-64BA126865F0Q33779029-C802F41C-354C-4D26-8F58-DF7F908522F8Q34227712-2A8A5292-3154-466A-A450-671977C87CB0Q34458290-B1E1021B-7F71-47BA-A44C-FD434B195D42Q35164608-1B30333C-E69D-41B8-9D67-AF30EF91BFC5Q35176325-6FB02C97-C0A6-4692-99C8-5A26C9E9D2F6Q35751304-3D02C56C-CB4C-4D31-B8C6-23788140EA8FQ37013289-51C5F578-E776-4848-984D-9C761D8D754FQ37176425-6596C30A-2B38-4533-A925-D8BB3B26A8DDQ38151582-1AA130D5-9469-4706-BD5A-FDED4FF8EF82Q38208182-D8627D64-0A4A-467C-BB72-624BFAD642A4Q38557236-F3B0DCF1-4F56-4DC9-813C-720311F46D3DQ38780472-164BC61F-D9FE-428D-ACC8-223C09DDD1ECQ38818584-86BB80E8-52C5-4FFD-9AAF-7C1C3A9E4C58Q38829417-27ACED74-8FB1-4C87-8F18-B7FAB58D5159Q38847625-A88F7C38-F90E-481C-95B2-DC0C2C1DAC72Q38848213-55D9426B-F9F8-4A71-BF74-C44ED066D3D0Q38966633-6F5FB886-91AC-4A8F-83AD-8162DCCB8CDCQ39653025-62E83B55-9F2E-4A3B-AB24-CF2378B97758Q39692548-87133820-4936-4A5D-BF1C-F7D449CBE25AQ40279363-EE48B9F8-2ED1-4AE3-9392-743D27966B99Q40450600-1DE5EC64-79A4-40FB-A850-A115D47F1B0BQ41288638-63C968D0-5CC5-41ED-97B5-79F1AFF83E5EQ41453815-5A879644-0D62-4FC8-A6C5-79C091C8B652Q41472948-6ADC4758-181C-4B86-997C-298EE17E03CCQ41593236-503A817F-B0D6-4BB8-A6ED-EC90744D1FAAQ41708897-46FE0F73-DCB8-4F89-AE48-85CAB53904A9Q41809872-0C954D15-CE4A-4B06-9120-3A252CC49FB8Q41865517-AB9230CB-9C0A-4889-AE85-BBED7B3D76F0Q42498049-DFE257FB-0F48-48AD-8FBC-4AAF3DDFA425Q47101149-0458967D-DB6E-414F-8656-EFCC6B448F37Q47347659-71087EFD-E354-495A-A37A-94D645994012Q47357002-A99FEA01-B09E-4BAC-8AD6-74EBD25354F9Q47566428-8499BF09-4F64-466F-98A0-B0DEE8A0024BQ47773621-9A660BF1-8C2D-4BA8-BDB8-74F463C14331Q48268624-DCA95FBF-F845-4515-B4BC-A25DC63EA254Q48285231-6945D5F7-7CA7-4333-B01C-BD55D51F7EC1Q48297033-66DF9763-B0B5-491B-8946-EB63E44F9697Q51238685-02516409-2F83-4D22-8734-43F3C7DC276C
P2860
Interleukins in glioblastoma pathophysiology: implications for therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Interleukins in glioblastoma pathophysiology: implications for therapy.
@en
type
label
Interleukins in glioblastoma pathophysiology: implications for therapy.
@en
prefLabel
Interleukins in glioblastoma pathophysiology: implications for therapy.
@en
P2093
P2860
P356
P1476
Interleukins in glioblastoma pathophysiology: implications for therapy
@en
P2093
P2860
P304
P356
10.1111/BPH.12008
P407
P577
2013-02-01T00:00:00Z